{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:35:43Z","timestamp":1793698543344,"version":"4.5.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Stanley W. Ekstrom Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Inflammation plays a crucial role in atherosclerosis and coronary artery disease progression. Colchicine, an inexpensive anti-inflammatory medication, has shown promising results in reducing cardiovascular events in patients with stable coronary artery disease (CAD). However, its effect on coronary plaque progression remains unclear. We investigated whether colchicine, as an adjunct to standard of care therapy, affects coronary plaque components in patients with stable CAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We performed a prospective, randomized, double-blinded, placebo-controlled trial in 84 patients with stable CAD to receive either colchicine (0.5\u2005mg\/day) or placebo for 12\u2005months. All enrolled patients had proven coronary artery disease as evidenced by coronary angiography, CT coronary angiography, or a Coronary Artery Calcium Score &amp;gt;400. The primary outcome was the rate of change in low attenuation plaque (LAP) volume, as measured by serial coronary computed tomography angiography (CCTA), utilizing volumetric plaque quantification software at 12\u2005months between colchicine and placebo groups. The secondary endpoint was total plaque percent atheroma volume (PAV%). The sample size was set assuming a treatment difference of at least 8\u2005mm\u00b3 change in LAP volume in favour of colchicine compared to placebo. The mean age of the 72 participants who completed the study was 64.6 \u00b1 7.3\u2005years, with 63 (88%) subjects being male. Baseline demographics, risk factors, medications, vitals, and inflammatory markers were not significantly different between the colchicine and placebo groups. One exception was that the colchicine group had significantly higher use of hypertension medications (75% vs. 44%) at the study start. There was no significant difference in the change in total LAP between the colchicine group with median (IQR) 0.1 (\u221202, 0.2) vs. 0.0 (\u22120.2, 0.3) in placebo, un-adjusted P = 0.342. Multivariable models, including known CV risk factors and baseline LAP, also showed no significant difference between the changes in LAP between treatment and placebo groups. A treatment effect was observed in the total PAV%. Follow-up total PAV at 12-month scan was significantly lower at median (IQR) 0.3 (\u22120.1, 1.3) in the colchicine group vs. 1.4 (0.4, 2.6) in placebo, P = 0.008 (unadjusted). In multivariate models, colchicine treatment was associated with lower PAV at 1\u2005year, P = 0.015. Trends toward regression in non-calcified and fibro-fatty plaque were observed. Inflammatory markers were reduced with colchicine, but did not achieve statistical significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the EKSTROM trial, low-dose colchicine did not significantly reduce low attenuation plaque volume in patients with stable coronary artery disease over 12\u2005months, but did achieve a significant reduction in total plaque burden (percent atheroma volume) and dense calcified plaque compared to placebo. Colchicine was well tolerated, with no major safety concerns. In this stable well-treated CAD population, LAP was rare and not significantly reduced; however, it slowed overall plaque progression, supporting further investigation of its role in secondary prevention of coronary artery disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>EKSTROM Trial<\/jats:title>\n                    <jats:p>NCT06342609.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjci\/jeag028","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:13:52Z","timestamp":1769422432000},"page":"682-692","source":"Crossref","is-referenced-by-count":12,"title":["Effect of colchicine on progression of known coronary atherosclerosis in patients with stable coronary artery disease: EKSTROM randomized placebo controlled trial"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9616-1946","authenticated-orcid":false,"given":"Matthew J","family":"Budoff","sequence":"first","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beshoy","family":"Iskander","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K","family":"Ghanem","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2720-3508","authenticated-orcid":false,"given":"April","family":"Kinninger","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Stark","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijendra","family":"Garikapati","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreya","family":"Chilukuri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Hankil","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natdanai","family":"Punnanithinont","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Kambalapalli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Hamal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1999-5314","authenticated-orcid":false,"given":"Suvasini","family":"Lakshmanan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center , 1124 W Carson Street, CDCRC, Torrance, CA 90502, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2026032621015422200_jeag028-B1","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026032621015422200_jeag028-B2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"2026032621015422200_jeag028-B3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026032621015422200_jeag028-B4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026032621015422200_jeag028-B5","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"2026032621015422200_jeag028-B6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026032621015422200_jeag028-B7","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"2026032621015422200_jeag028-B8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11883-013-0391-z","article-title":"Colchicine for secondary prevention of cardiovascular disease","volume":"16","author":"Nidorf","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"2026032621015422200_jeag028-B9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ahj.2024.07.005","article-title":"Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial-rationale and design","volume":"277","author":"Verghese","year":"2024","journal-title":"Am Heart J"},{"key":"2026032621015422200_jeag028-B10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcct.2010.09.006","article-title":"Quantitative measurements of coronary arterial stenosis, plaque geometry, and composition are highly reproducible with a standardized coronary arterial computed tomographic approach in high-quality CT datasets","volume":"5","author":"Rinehart","year":"2011","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2026032621015422200_jeag028-B11","doi-asserted-by":"crossref","first-page":"107840","DOI":"10.1016\/j.jdiacomp.2020.107840","article-title":"Prevalence of normal coronary arteries by coronary computed tomography angiography (CCTA) in patients with type 2 diabetes mellitus from Semaglutide Treatment on Coronary Plaque Progression (STOP) trial","volume":"35","author":"Birudaraju","year":"2021","journal-title":"J Diabetes Complications"},{"key":"2026032621015422200_jeag028-B12","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehaa652","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial","volume":"41","author":"Budoff","year":"2020","journal-title":"Eur Heart J"},{"key":"2026032621015422200_jeag028-B13","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1007\/s00330-008-1019-5","article-title":"Characterization of coronary atherosclerosis by dual-source computed tomography and HU-based color mapping: a pilot study","volume":"18","author":"Brodoefel","year":"2008","journal-title":"Eur Radiol"},{"key":"2026032621015422200_jeag028-B14","doi-asserted-by":"crossref","first-page":"427S","DOI":"10.3945\/jn.114.202424","article-title":"Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with metabolic syndrome in a prospective randomized double-blind study","volume":"146","author":"Matsumoto","year":"2016","journal-title":"J Nutr"},{"key":"2026032621015422200_jeag028-B15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2016.11.004","article-title":"Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: a propensity-score matching study","volume":"255","author":"Nakanishi","year":"2016","journal-title":"Atherosclerosis"},{"key":"2026032621015422200_jeag028-B16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.atherosclerosis.2013.08.019","article-title":"Effect of statin treatment on coronary plaque progression\u2014a serial coronary CT angiography study","volume":"231","author":"Zeb","year":"2013","journal-title":"Atherosclerosis"},{"key":"2026032621015422200_jeag028-B17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2018.08.007","article-title":"Randomized trial of rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis","volume":"206","author":"Lee","year":"2018","journal-title":"Am Heart J"},{"key":"2026032621015422200_jeag028-B18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ahj.2019.02.014","article-title":"Apixaban versus warfarin in evaluation of progression of atherosclerotic and calcified plaques (prospective randomized trial)","volume":"212","author":"Win","year":"2019","journal-title":"Am Heart J"},{"key":"2026032621015422200_jeag028-B19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"key":"2026032621015422200_jeag028-B20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.124.069808","article-title":"Colchicine and coronary plaque phenotype in patients with acute coronary syndrome: the COLOCT randomized clinical trial","volume":"150","author":"Yu","year":"2024","journal-title":"Circulation"},{"key":"2026032621015422200_jeag028-B21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N Engl J Med"},{"key":"2026032621015422200_jeag028-B22","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"2026032621015422200_jeag028-B23","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"2026032621015422200_jeag028-B24","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"key":"2026032621015422200_jeag028-B25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00019501-200606000-00006","article-title":"Assessment of coronary plaque morphology by contrast-enhanced computed tomographic angiography: comparison with intravascular ultrasound","volume":"17","author":"Rasouli","year":"2006","journal-title":"Coron Artery Dis"},{"key":"2026032621015422200_jeag028-B26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.14503\/THIJ-15-5212","article-title":"Changes in coronary plaque volume: comparison of serial measurements on intravascular ultrasound and coronary computed tomographic angiography","volume":"45","author":"Nakanishi","year":"2018","journal-title":"Tex Heart Inst J"},{"key":"2026032621015422200_jeag028-B27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jcct.2013.08.006","article-title":"Coronary CT angiography versus intravascular ultrasound for estimation of coronary stenosis and atherosclerotic plaque burden: a meta-analysis","volume":"7","author":"Fischer","year":"2013","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2026032621015422200_jeag028-B28","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"2026032621015422200_jeag028-B29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tcm.2019.01.001","article-title":"Effect of statins on atherosclerotic plaque","volume":"29","author":"Almeida","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"2026032621015422200_jeag028-B30","first-page":"341","article-title":"Colchicine\u2014update on mechanisms ofaction and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"SeminArthritis Rheum"},{"key":"2026032621015422200_jeag028-B31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4103\/idoj.IDOJ_475_20","article-title":"Colchicine in dermatology:rediscovering an old drug with noveluses","volume":"11","author":"Sardana","year":"2020","journal-title":"Indian Dermatol Online J"},{"key":"2026032621015422200_jeag028-B32","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish computed tomography of the HEART)","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation"},{"key":"2026032621015422200_jeag028-B33","first-page":"68","article-title":"Colchicine and plaque: a focus on atherosclerosis imaging","volume":"84","author":"Aldana-Bitar","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"key":"2026032621015422200_jeag028-B34","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jcmg.2016.10.024","article-title":"Pericardial, but not hepatic, fat by CT is associated with CV outcomes and structure: the multi-ethnic study of atherosclerosis","volume":"10","author":"Shah","year":"2017","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeag028\/66849939\/jeag028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeag028\/66849939\/jeag028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeag028\/66849939\/jeag028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T01:02:02Z","timestamp":1774573322000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/4\/682\/8472488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2,11]]},"published-print":{"date-parts":[[2026,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeag028","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,2,11]]}}}